Utilization of a mutagenesis screen to generate mouse models of hyperaldosteronism
- PMID: 21068155
- DOI: 10.1210/en.2010-1081
Utilization of a mutagenesis screen to generate mouse models of hyperaldosteronism
Abstract
Primary aldosteronism is considered to be responsible for almost 10% of all cases of arterial hypertension. The genetic background of this common disease, however, has been elucidated only for the rare familial types, whereas in the large majority of sporadic cases, underlying mechanisms still remain unclear. In an attempt to define novel genetic loci involved in the pathophysiology of primary aldosteronism, a mutagenesis screen after treatment of mice with the alkylating agent N-ethyl-N-nitrosourea was established for the parameter aldosterone. As the detection method we used a time-resolved fluorescence immunoassay that allows the measurement of aldosterone in very small murine sample volumes. Based on this assay, we first determined the normal aldosterone values for wild-type C3HeB/FeJ mice under baseline conditions [92 ± 6 pg/ml for females (n = 69) and 173 ± 16 pg/ml for males (n = 55)]. Subsequently, aldosterone measurement was carried out in more than 2800 F(1) offspring of chemically mutagenized C3HeB/FeJ mice, and values were compared with aldosterone levels from untreated animals. Persistent hyperaldosteronism (defined as levels +3 sd above the mean of untreated animals) upon repeated measurements was present in seven female and two male F(1) offspring. Further breeding of these founders gave rise to F(2) pedigrees from which eight lines with different patterns of inheritance of hyperaldosteronism could be established. These animals will serve for detailed phenotypic and genetic characterization in the future. Taken together, our data demonstrate the feasibility of a phenotype-driven mutagenesis screen to detect and establish mutant mouse lines with a phenotype of chronic hyperaldosteronism.
Similar articles
-
Genetic characterization of a mouse line with primary aldosteronism.J Mol Endocrinol. 2017 Feb;58(2):67-78. doi: 10.1530/JME-16-0200. Epub 2016 Dec 13. J Mol Endocrinol. 2017. PMID: 27965370
-
Enu mouse mutagenesis: generation of mouse mutants with aberrant plasma IgE levels.Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):25-8. doi: 10.1159/000053659. Int Arch Allergy Immunol. 2001. PMID: 11306917
-
Animal models of primary aldosteronism.Ann Endocrinol (Paris). 2009 Jun;70(3):168-72. doi: 10.1016/j.ando.2009.02.010. Epub 2009 Mar 17. Ann Endocrinol (Paris). 2009. PMID: 19296925
-
Animal models of primary aldosteronism.Horm Metab Res. 2010 Jun;42(6):446-9. doi: 10.1055/s-0029-1243205. Horm Metab Res. 2010. PMID: 20013646 Review.
-
An update on novel mechanisms of primary aldosteronism.J Endocrinol. 2015 Feb;224(2):R63-77. doi: 10.1530/JOE-14-0597. Epub 2014 Nov 25. J Endocrinol. 2015. PMID: 25424518 Review.
Cited by
-
Deoxyguanosine kinase mutation F180S is associated with a lean phenotype in mice.Int J Obes (Lond). 2023 Mar;47(3):215-223. doi: 10.1038/s41366-023-01262-z. Epub 2023 Jan 28. Int J Obes (Lond). 2023. PMID: 36709400 Free PMC article.
-
Chemogenetic activation of adrenocortical Gq signaling causes hyperaldosteronism and disrupts functional zonation.J Clin Invest. 2020 Jan 2;130(1):83-93. doi: 10.1172/JCI127429. J Clin Invest. 2020. PMID: 31738186 Free PMC article.
-
Mouse Models of Primary Aldosteronism: From Physiology to Pathophysiology.Endocrinology. 2017 Dec 1;158(12):4129-4138. doi: 10.1210/en.2017-00637. Endocrinology. 2017. PMID: 29069360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous